8-78792165-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_000880.4(IL7):​c.147+5907C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 152,070 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.017 ( 24 hom., cov: 32)

Consequence

IL7
NM_000880.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.117

Publications

6 publications found
Variant links:
Genes affected
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0168 (2551/152070) while in subpopulation SAS AF = 0.0193 (93/4812). AF 95% confidence interval is 0.0175. There are 24 homozygotes in GnomAd4. There are 1303 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7NM_000880.4 linkc.147+5907C>A intron_variant Intron 2 of 5 ENST00000263851.9 NP_000871.1 P13232-1A8K673

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7ENST00000263851.9 linkc.147+5907C>A intron_variant Intron 2 of 5 1 NM_000880.4 ENSP00000263851.4 P13232-1

Frequencies

GnomAD3 genomes
AF:
0.0168
AC:
2550
AN:
151952
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0113
Gnomad AMI
AF:
0.00659
Gnomad AMR
AF:
0.0140
Gnomad ASJ
AF:
0.0294
Gnomad EAS
AF:
0.0145
Gnomad SAS
AF:
0.0193
Gnomad FIN
AF:
0.0273
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0184
Gnomad OTH
AF:
0.0221
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0168
AC:
2551
AN:
152070
Hom.:
24
Cov.:
32
AF XY:
0.0175
AC XY:
1303
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.0113
AC:
470
AN:
41494
American (AMR)
AF:
0.0140
AC:
214
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0294
AC:
102
AN:
3468
East Asian (EAS)
AF:
0.0145
AC:
75
AN:
5164
South Asian (SAS)
AF:
0.0193
AC:
93
AN:
4812
European-Finnish (FIN)
AF:
0.0273
AC:
289
AN:
10582
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0184
AC:
1249
AN:
67976
Other (OTH)
AF:
0.0218
AC:
46
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
127
254
381
508
635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00493
Hom.:
2
Bravo
AF:
0.0158
Asia WGS
AF:
0.0120
AC:
41
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.35
DANN
Benign
0.33
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2583760; hg19: chr8-79704400; API